chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Uveitis
Clinical narrative: After receiving the Covid-19 vaccine on 5/16/2021, Pt started to complain of light sensitivity and headache on 6/4/2021. The symptoms worsened and on 6/5/2021 she was presenting with  light sensitivity,  headache, and bloodshot eyes. On 6/6/2021 we brought her to urgent care and she was misdiagnosed with an eye infection and prescribed antibiotics.  On 6/10/2021 we saw Dr., who diagnosed Pt with Uveitis and referred us to Uveitis specialist, Dr. and Dr. Dr. prescribe Pred Forte, which Pt used for 2 weeks, however, no improvement was seen, so Dr. prescribed Durazol. We attempted to wean Pt off of Durazol 3 times between July 2021 and February 2022, but the Uveitis did not clear and Pt continued to experience flare ups. In February 2022, we switched to Methotrexate when Pt began to develop cataracts from the Durazol and the continued Uveitis flares. We were able to fully end Durazol drops in May 2022 with the Methotrexate treatment. Trace cells continued to persist into June 2022 with exclusive Methotrexate treatment, so we increased the dosage to the maximum. In July 2022 Pt was nearly clear of all trace cells on the maximum dosage of Methotrexate, which we inject weekly. Our plan is to continue this treatment for 2 years or more if needed.  Our hope is that we will eventually be able to wean Pt off of the Methotrexate. We are hoping that she does not experience any of the very sever potential complications from Methotrexate. We are monitoring  the cataracts effect on Pt's vision and will begin to meet with doctors to discuss future cataract surgery. At this time the final outcome of Pt's vaccine induced Uveitis event is unknown.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Anal incontinence, Cardiac arrest, Cerebrovascular accident, Confusional state, Death
Clinical narrative: Heart attack on 7/24/21 along with confusion, loss of bowels. Diagnosed with broken heart syndrome. Hospitalized. Then suffered a stroke on 8/22/21.  Passed away from heart stopping on 9/12/21.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Myocardial infarction, Stress cardiomyopathy
Clinical narrative: Heart attack on 7/24/21 along with confusion, loss of bowels. Diagnosed with broken heart syndrome. Hospitalized. Then suffered a stroke on 8/22/21.  Passed away from heart stopping on 9/12/21.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Gait disturbance, Hypotension, Lethargy
Clinical narrative: Lethargy, chills, low blood pressure and ambulating difficulty without assistance.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Alanine aminotransferase normal, Anion gap, Aspartate aminotransferase normal, Asthenia, Basophil count decreased
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Basophil percentage, Bilirubin urine, Blood albumin decreased, Blood alkaline phosphatase normal, Blood bilirubin increased
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood calcium normal, Blood chloride normal, Blood creatine phosphokinase increased, Blood creatinine increased, Blood glucose increased
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood magnesium normal, Blood potassium decreased, Blood sodium normal, Blood urea increased, Blood urine present
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, Carbon dioxide normal, Cardiac failure congestive, Chest X-ray abnormal
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chromaturia, Dyspnoea, Eosinophil count decreased, Eosinophil percentage, Glomerular filtration rate decreased
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Glucose urine, Granulocyte count, Granulocyte percentage, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza A virus test negative, Influenza B virus test, Lymphocyte count decreased, Lymphocyte percentage decreased
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal, Mean platelet volume increased
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Monocyte count increased, Monocyte percentage increased, Myalgia, Nausea, Nitrite urine absent
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Platelet count normal, Protein total normal, Protein urine present, Red blood cell count decreased, Red blood cells urine positive
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Red cell distribution width increased, Respiratory syncytial virus test negative, SARS-CoV-2 test positive, Specific gravity urine normal, Troponin I increased
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary casts, Urinary sediment present, Urine ketone body absent, Urine leukocyte esterase, Urobilinogen urine decreased
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting, White blood cell count normal, White blood cells urine negative, pH urine normal
Clinical narrative: Narrative:  *Pt COVID positive despite 3 doses of COVID vaccine. 11/9/2021 - #3 dose of vaccine received at facility - Moderna. 7/2/2022 Pt seen at facility ER, then admitted to medical floor. Admitted 7/3/2022 - 7/12/2022. Pt treated with 5d of Remdesivir. 69 yo F with pmhx listed below who was brought in by EMS for progressive weakness, malaisa and worsening SOB x 5 days. She denies fever, chills, anosmia or dysgeusia but endorses myalgias, nausea and vomiting. On arrival to the ER, her COVID test came back positive. CXR was consistent with mild CHF and her BNP was ~ 3000. Her Creatinine was at baseline at ~ 2.0. Her SBP was also noted to be >200. She endorses mild HA, denies palpitations or CP.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time shortened, Acute respiratory failure, Alanine aminotransferase normal, Anion gap, Aspartate aminotransferase normal
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Basophil count normal, Basophil percentage, Bilirubin conjugated, Blood albumin normal, Blood alkaline phosphatase normal
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bilirubin normal, Blood calcium normal, Blood chloride decreased, Blood creatinine normal, Blood glucose normal
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid, Blood potassium decreased, Blood sodium normal, Blood urea decreased, COVID-19
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Carbon dioxide normal, Cough, Dyspnoea, Eosinophil count normal, Eosinophil percentage
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Glomerular filtration rate normal, Granulocyte count, Granulocyte percentage, Haematocrit normal, Haemoglobin normal
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Influenza A virus test negative, Influenza B virus test, International normalised ratio normal, Lymphocyte count
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphocyte percentage, Mean cell haemoglobin concentration normal, Mean cell haemoglobin increased, Mean cell volume normal, Mean platelet volume normal
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Monocyte count, Monocyte percentage increased, Nasal congestion, Oropharyngeal pain, Platelet count normal
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin, Protein total normal, Prothrombin time prolonged, Red blood cell count normal, Red cell distribution width increased
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory syncytial virus test negative, SARS-CoV-2 test positive, White blood cell count normal
Clinical narrative: Narrative:  Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022 - Patient presents to the emergency department complaint of shortness of breath since onset of a cough this past Thursday. Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022 - 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure - Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Chest X-ray normal, Chills, Dyspnoea
Clinical narrative: Narrative:  this is a 62 years old male who was received as a transfer from another Hospital emergency room. Patient presented to OSH for generalized aches, shortness of breath and productive cough associated with intermittent fever and chills. As per patient he was here last Tuesday for his podiatry appointment and was asymptomatic. Patient started feeling sick yesterday. He has had 2 Covid vaccines and denies any known sick contacts. Smokes 1 pack/day. On arrival to first hospital patient was noted with SPO2 levels below 90 and he was requiring 3 L to keep SPO2 above 92%. He does not wear oxygen at home. Chest x-ray showed no evidence of pneumonia and remains without any elevation of inflammatory markers. Additionally patient has history of coronary artery disease, with significant lesions noted in the right coronary artery on angiography performed in 2002. The patient did undergo percutaneous intervention of both the proximal and the distal bifurcational stenoses. ASSESSMENT & PLAN ************* 1) COVID illness with acute hypoxic respiratory failure requiring supplemental oxygen 3 L by nasal cannula
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Inflammatory marker test, Malaise, Pain, Productive cough, Pyrexia
Clinical narrative: Narrative:  this is a 62 years old male who was received as a transfer from another Hospital emergency room. Patient presented to OSH for generalized aches, shortness of breath and productive cough associated with intermittent fever and chills. As per patient he was here last Tuesday for his podiatry appointment and was asymptomatic. Patient started feeling sick yesterday. He has had 2 Covid vaccines and denies any known sick contacts. Smokes 1 pack/day. On arrival to first hospital patient was noted with SPO2 levels below 90 and he was requiring 3 L to keep SPO2 above 92%. He does not wear oxygen at home. Chest x-ray showed no evidence of pneumonia and remains without any elevation of inflammatory markers. Additionally patient has history of coronary artery disease, with significant lesions noted in the right coronary artery on angiography performed in 2002. The patient did undergo percutaneous intervention of both the proximal and the distal bifurcational stenoses. ASSESSMENT & PLAN ************* 1) COVID illness with acute hypoxic respiratory failure requiring supplemental oxygen 3 L by nasal cannula
Age: 72.0
Sex: M
Vaccine: PPV
Symptoms: Injection site swelling
Clinical narrative: Narrative:  Patient visited the ER on 5/4/22 where physician stated that swelling of the injection site looked abnormal. There was a working diagnosis of possible cellulitis. After initiating cephalexin, the patient's arm greatly improved after2 days. Unable to determine if cephalexin administration correlated with improvement in symptoms.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Neck pain, Oropharyngeal pain
Clinical narrative: Myalgia, Arthralgia, Fever, fatigue Narrative: Initially, left arm hurt. by PM muscles felt very sore. low grade fever, excessive fatigue. 07/16/22 geadacgem neck pain, sore thorat
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Myalgia, Arthralgia, Fever, fatigue Narrative: Initially, left arm hurt. by PM muscles felt very sore. low grade fever, excessive fatigue. 07/16/22 geadacgem neck pain, sore thorat
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Myalgia, Pyrexia
Clinical narrative: Dizziness, Myalgia & Fever Narrative:
Age: 63.0
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Myalgia
Clinical narrative: Myalgia fatigue, injection site pain Narrative:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Myalgia, Fever & NauseaVomiting Narrative:
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Loss of consciousness, Pallor
Clinical narrative: Patient was given vaccine (Pfizer Biotech) around 1:00 pm on 07/29/2022, got up from chair and stood for a moment. Patient turned pale, blacked out and feel forward. Patient quickly come to and in 15 mins was back to normal
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Heart rate increased, Immunisation reaction, Laboratory test
Clinical narrative: Rapid heart rate, and chest pain directly after vaccine. A year later I have the same symptoms chest pain and rapid heart rate
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Thrombosis
Clinical narrative: blood clot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP), Program ID:. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: THROMBOSIS (medically significant), outcome "unknown", described as "blood clot". Clinical course: The data that showed current blood clot side effects of the booster dose for the covid 19 vaccine because he experienced blood clot on his first booster shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neck pain
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25May2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 28Aug2021 as dose 2, single (Lot number: EWU179) at the age of 32 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: Magnetic resonance imaging: (unspecified date) hypertrophic change in C1-C2 joint, notes: No injury or other reason for this change; SARS-CoV-2 test: (Jan2022) Positive. Clinical course: No other vaccine in four weeks. No other medications in two weeks. Pain in neck beginning approximately one week after vaccine. MRI results show hypertrophic change in C1-C2 joint. No injury or other reason for this change. Start date 02Jun2021. Treatment of physical therapy, chiropractic treatment, MRI. The patient did not had covid prior vaccination. Covid test type post vaccination- nasal swab. No known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201017896 Same product, patient, different AEs, different dose;
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, Magnetic resonance imaging, SARS-CoV-2 test
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25May2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 28Aug2021 as dose 2, single (Lot number: EWU179) at the age of 32 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: Magnetic resonance imaging: (unspecified date) hypertrophic change in C1-C2 joint, notes: No injury or other reason for this change; SARS-CoV-2 test: (Jan2022) Positive. Clinical course: No other vaccine in four weeks. No other medications in two weeks. Pain in neck beginning approximately one week after vaccine. MRI results show hypertrophic change in C1-C2 joint. No injury or other reason for this change. Start date 02Jun2021. Treatment of physical therapy, chiropractic treatment, MRI. The patient did not had covid prior vaccination. Covid test type post vaccination- nasal swab. No known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201017896 Same product, patient, different AEs, different dose;
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Antinuclear antibody, Blood test, C-reactive protein, Inappropriate schedule of product administration, Investigation
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25May2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 28Aug2021 as dose 2, single (Lot number: EWU179) at the age of 32 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: Magnetic resonance imaging: (unspecified date) hypertrophic change in C1-C2 joint, notes: No injury or other reason for this change; SARS-CoV-2 test: (Jan2022) Positive. Clinical course: No other vaccine in four weeks. No other medications in two weeks. Pain in neck beginning approximately one week after vaccine. MRI results show hypertrophic change in C1-C2 joint. No injury or other reason for this change. Start date 02Jun2021. Treatment of physical therapy, chiropractic treatment, MRI. The patient did not had covid prior vaccination. Covid test type post vaccination- nasal swab. No known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201017896 Same product, patient, different AEs, different dose;
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging, Movement disorder, Neck pain, Red blood cell sedimentation rate, SARS-CoV-2 test
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25May2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 28Aug2021 as dose 2, single (Lot number: EWU179) at the age of 32 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: Magnetic resonance imaging: (unspecified date) hypertrophic change in C1-C2 joint, notes: No injury or other reason for this change; SARS-CoV-2 test: (Jan2022) Positive. Clinical course: No other vaccine in four weeks. No other medications in two weeks. Pain in neck beginning approximately one week after vaccine. MRI results show hypertrophic change in C1-C2 joint. No injury or other reason for this change. Start date 02Jun2021. Treatment of physical therapy, chiropractic treatment, MRI. The patient did not had covid prior vaccination. Covid test type post vaccination- nasal swab. No known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201017896 Same product, patient, different AEs, different dose;
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Cardiac arrest, Hypertension
Clinical narrative: my wife passed away after taking your covid vaccine.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:.  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "my wife passed away after taking your covid vaccine.". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: My wife passed away after taking your covid vaccine.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: my wife passed away after taking your covid vaccine.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:.  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "my wife passed away after taking your covid vaccine.". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: My wife passed away after taking your covid vaccine.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Chills, Cough, Decreased appetite, Gait inability
Clinical narrative: Tested positive; Tested positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 75-year-old female patient received BNT162b2 (BNT162B2), on 13Mar2021 at 14:00 as dose 1, single (Lot number: EN6200), in left arm, on 01Apr2021 at 15:00 as dose 2, single (Lot number: EP7534), in left arm, on 22Nov2021 at 23:00 as dose 3 (booster), single (Lot number: FH8030, Expiration Date: 28Feb2022), in left arm and on 31May2022 at 11:00 as dose 4 (booster), single (Lot number: FM0173) at the age of 75 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 02Jun2022 at 08:00, outcome "recovering" and all described as "Tested positive". She got her covid shot on 31May2022. She tested positive on 02Jun2022. She self-isolated and treated herself with old covid medicine and antibiotic from an old dental work. She stayed sick for the first part of Jun. She started feeling a little better around 14Jun2022. She was able to leave her house. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Jun2022) Positive, notes: I tested positive on 02Jun2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Influenza like illness, Nasal congestion, Nausea, Pain
Clinical narrative: Tested positive; Tested positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 75-year-old female patient received BNT162b2 (BNT162B2), on 13Mar2021 at 14:00 as dose 1, single (Lot number: EN6200), in left arm, on 01Apr2021 at 15:00 as dose 2, single (Lot number: EP7534), in left arm, on 22Nov2021 at 23:00 as dose 3 (booster), single (Lot number: FH8030, Expiration Date: 28Feb2022), in left arm and on 31May2022 at 11:00 as dose 4 (booster), single (Lot number: FM0173) at the age of 75 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 02Jun2022 at 08:00, outcome "recovering" and all described as "Tested positive". She got her covid shot on 31May2022. She tested positive on 02Jun2022. She self-isolated and treated herself with old covid medicine and antibiotic from an old dental work. She stayed sick for the first part of Jun. She started feeling a little better around 14Jun2022. She was able to leave her house. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Jun2022) Positive, notes: I tested positive on 02Jun2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Somnolence
Clinical narrative: Tested positive; Tested positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 75-year-old female patient received BNT162b2 (BNT162B2), on 13Mar2021 at 14:00 as dose 1, single (Lot number: EN6200), in left arm, on 01Apr2021 at 15:00 as dose 2, single (Lot number: EP7534), in left arm, on 22Nov2021 at 23:00 as dose 3 (booster), single (Lot number: FH8030, Expiration Date: 28Feb2022), in left arm and on 31May2022 at 11:00 as dose 4 (booster), single (Lot number: FM0173) at the age of 75 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 02Jun2022 at 08:00, outcome "recovering" and all described as "Tested positive". She got her covid shot on 31May2022. She tested positive on 02Jun2022. She self-isolated and treated herself with old covid medicine and antibiotic from an old dental work. She stayed sick for the first part of Jun. She started feeling a little better around 14Jun2022. She was able to leave her house. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Jun2022) Positive, notes: I tested positive on 02Jun2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Tested positive; Tested positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 75-year-old female patient received BNT162b2 (BNT162B2), on 13Mar2021 at 14:00 as dose 1, single (Lot number: EN6200), in left arm, on 01Apr2021 at 15:00 as dose 2, single (Lot number: EP7534), in left arm, on 22Nov2021 at 23:00 as dose 3 (booster), single (Lot number: FH8030, Expiration Date: 28Feb2022), in left arm and on 31May2022 at 11:00 as dose 4 (booster), single (Lot number: FM0173) at the age of 75 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 02Jun2022 at 08:00, outcome "recovering" and all described as "Tested positive". She got her covid shot on 31May2022. She tested positive on 02Jun2022. She self-isolated and treated herself with old covid medicine and antibiotic from an old dental work. She stayed sick for the first part of Jun. She started feeling a little better around 14Jun2022. She was able to leave her house. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Jun2022) Positive, notes: I tested positive on 02Jun2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.
Age: 74.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Erythema, Inflammation, Pain
Clinical narrative: Redness, Swelling, blister below the skin with some bruising
Age: 74.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Blister, Contusion, Erythema, Swelling
Clinical narrative: Redness, Swelling, blister below the skin with some bruising
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: did not work- Covid vaccines; did not work- Covid vaccines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), on 09Feb2021 as dose 1, single (Lot number: EN9581), on 02Mar2021 as dose 2, single (Lot number: EN6206), on 27Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 19Apr2022 as dose 4 (booster), single (Lot number: FK9894) at the age of 69 years for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ROSUVASTATIN, stop date: 24Jul2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 24Jul2022, outcome "not recovered" and all described as "did not work- Covid vaccines". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Jul2022) Positive, notes: she tested positive on Sunday 24Jul2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Caller stated she had Covid, stated she was miserable, got two booster vaccine did not work. She tested positive on Sunday 24Jul2022, the same day she started taking Paxlovid. Caller stated she took a ton of medication, told her to stop taking the statin so she did, she was taking rosuvastatin, stopped taking it on Sunday night 24Jul2022. She was instructed too but she knew she needed to because she saw that another patient (withheld) was taking a statin and was prescribed Paxlovid and had to pause his statin medication.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.